Why was there any need to change from 1996 criteria?
Late 1990s onwards:
• Haematology analysers flag cases with a lymphocyte count above 3.5 x 10 9 /L or with some atypical lymphs as being "abnormal" -5 x 10 9 /L => CLL incidence stable, MBL = very low risk -10 x 10 9 L=> CLL incidence changes, MBL = intermediate risk -MGUS / Myeloma situation is generally practical for patients and clinicians so some equivalent is likely to remain
• The risk of progression in MBL can be very troubling for people with the disorder but perhaps should not be the primary concern • ? Debate should be about the level of CLL cells begins to have an impact on health (lower threshold) ?
CLL-phenotype cells detectable in a high proportion of the general population
• All cases (even <0.001 x 10 9 /L) have CLL phenotype and genotype (13q14, predisposition polymorphisms) 
CLL-like B-cells (low-count / population MBL) vs. CLL-like MBL (clinic MBL)

